Expression of ICAM-1 During IFN-alpha-Based Treatment of Metastatic Malignant Melanoma: Relation to Tumor-Infiltrating Mononuclear Cells and Regressive Tumor Changes

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Interferon and Cytokine Research

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/107999099314315PMID 10090402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of IFN-alpha on tumor-infiltrating mononuclear cells and regressive changes in metastatic malignant melanoma.

  1998cited by this paper
• Effect of IFN-α on Tumor-Infiltrating Mononuclear Cells and Regressive Changes in Metastatic Malignant Melanoma

  1998cited by this paper
• Serum levels of slCAM-1 and 5-S-cysteinyldopa as markers of melanoma progression

  1997cited by this paper
• Effect of interferon-alpha on the expression of tumour necrosis factor-alpha by metastatic malignant melanoma in vivo.

  1997cited by this paper
• Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

  1996cited by this paper
• Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.

  1996cited by this paper
• Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.

  1996cited by this paper
• Mechanism and Biological Significance of CD4‐mediated Cytotoxicity

  1995cited by this paper
• Leukocyte migration and adhesion.

  1995cited by this paper
• Cytokine‐mediated modulation of integrin, ICAM‐1 and CD44 expression on human uveal melanoma cells in vitro

  1995cited by this paper
• Intercellular Adhesion Molecule‐1 on Cultured Human Melanoma Cells: Influence of Cytokines

  1993cited by this paper
• Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852.

  1993cited by this paper
• Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.

  1993cited by this paper
• Histologic regression in malignant melanoma: an interobserver concordance study

  1993cited by this paper
• Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.

  1993cited by this paper
• Differential expression and release of LFA‐3 and ICAM‐1 in human melanoma cell lines

  1993cited by this paper
• Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells.

  1992cited by this paper
• Essentials of Medical Statistics

  1991cited by this paper
• Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.

  1991cited by this paper
• Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis.

  1991cited by this paper
• Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.

  1990influential reference
• Icam ‐ melanoma cells are relatively resistant to cd3‐mediated t‐cell lysis

  1990cited by this paper
• Cytokine‐mediated modulation of HLA‐class II, ICAM‐1, LFA‐3 and tumor‐associated antigen profile of melanoma cells. comparison with anti‐proliferative activity by RIL1‐β, RTNF‐α, RIFN‐γ, RIl4 and their combinations

  1990cited by this paper
• Structure and Function of Leukocyte Integrins

  1990cited by this paper
• The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.

  1990cited by this paper
• Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations.

  1990cited by this paper
• Adhesion receptors of the immune system

  1990cited by this paper
• Model predicting survival in stage I melanoma based on tumor progression.

  1989cited by this paper
• De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.

  1989cited by this paper
• Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen

  1988cited by this paper
• Inflammatory cell infiltrates in human melanoma at different stages of tumor progression

  1988cited by this paper
• Essentials of medical statistics.

  1988cited by this paper
• Thin malignant melanomas with regression and metastases.

  1987cited by this paper
• Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes

  1987cited by this paper
• Partial regression in thin primary cutaneous malignant melanomas clinical stage I

  1985cited by this paper
• A RETROSPECTIVE HISTOLOGICAL STUDY OF 669 CASES OF PRIMARY CUTANEOUS MALIGNANT MELANOMA IN CLINICAL STAGE I

  1979cited by this paper
• A Retrospective Histological Study of 669 Cases of Primary Cutaneous Malignant Melanoma in Clinical Stage I

  1978cited by this paper
• SPONTANEOUS REGRESSION OF MELANOMA

  1975cited by this paper
• Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck.

  1974cited by this paper

• Regressive melanoma in a female patient: A case report.

  2020cites this paper
• Cu�����u� �������� ��� b � ���������y d�����b�d �� ��

  2020cites this paper
• The effect of ALA-PDT under normoxia and cobalt chloride (CoCl2)-induced hypoxia on adhesion molecules (ICAM-1, VCAM-1) secretion by colorectal cancer cells.

  2017cites this paper
• Fully Regressive Melanoma: A Case Without Metastasis.

  2016cites this paper
• Interferon-alpha inhibits airway eosinophila and hyperresponsiveness in an animal asthma model

  2012cites this paper
• Erratum: Interferon-alpha inhibits airway eosinophila and hyperresponsiveness in an animal asthma model

  2012cites this paper
• Depressive Symptome, Störungen der Befindlichkeit und Beeinträchtigung des Alltagslebens unter einer adjuvanten Therapie maligner Melanome mit Interferon-alpha

  2009cites this paper
• Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha.

  2004cites this paper
• PCB 104-induced proinflammatory reactions in human vascular endothelial cells: relationship to cancer metastasis and atherogenesis.

  2003cites this paper